$ZVRA Investing.com - H.C. Wainwright reiterated a buy rating and $26.00 price target on Zevra Therapeutics shares following an investor dinner with the company’s management team in Boston. The firm said it came away increasingly positive on three key areas: -the continued gr

stocktwits · 2026-08-23 · Bullish AI sentiment

Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.

Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。